Population pharmacokinetics of kahalalide F in advanced cancer patients

Population pharmacokinetic-pharmacodynamic analysis for eribulin mesilate-associated neutropenia

(2013) J. G. Coen van Hasselt et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Phase I study of weekly kahalalide F as prolonged infusion in patients with advanced solid tumors

(2013) R. Salazar et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Predictive Factors of Sensitivity to Elisidepsin, a Novel Kahalalide F-Derived Marine Compound

(2013) Maria Serova et al.   Marine Drugs

A phase I and pharmacokinetic study of elisidepsin (PM02734) in patients with advanced solid tumors

(2012) R. Salazar et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

In vitro and in vivo evaluation of select kahalalide F analogs with antitumor and antifungal activities

(2011) Abbas Gholipour Shilabin et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Population pharmacokinetics of PM00104 (Zalypsis®) in cancer patients

(2011) Carlos Pérez-Ruixo et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Chemistry and Biology of Kahalalides

(2011) Jiangtao Gao et al.   CHEMICAL REVIEWS

The Bootstrap and Markov-Chain Monte Carlo

(2011) Bradley Efron   Journal of Biopharmaceutical Statistics

Handling Data Below the Limit of Quantification in Mixed Effect Models

(2009) Martin Bergstrand et al.   AAPS Journal

Importance of Shrinkage in Empirical Bayes Estimates for Diagnostics: Problems and Solutions

(2009) Radojka M. Savic et al.   AAPS Journal

Cancer Treatments: Can We Find Treasures at the Bottom of the Sea?

(2009) Mariano Provencio et al.   Clinical Lung Cancer

Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma

(2009) Salvador Martín-Algarra et al.   EUROPEAN JOURNAL OF CANCER

Kahalalide F, an Antitumor Depsipeptide in Clinical Trials, and Its Analogues as Effective Antileishmanial Agents

(2009) Luis J. Cruz et al.   MOLECULAR PHARMACEUTICS

Population pharmacokinetics meta-analysis of plitidepsin (Aplidin®) in cancer subjects

(2008) Ricardo Nalda-Molina et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Rapid Identification of a Protein Binding Partner for the Marine Natural Product Kahalalide F by Using Reverse Chemical Proteomics

(2008) Andrew M. Piggott et al.   CHEMBIOCHEM

Phase I Clinical and Pharmacokinetic Study of Kahalalide F Administered Weekly as a 1-Hour Infusion to Patients with Advanced Solid Tumors

(2008) B. Pardo et al.   CLINICAL CANCER RESEARCH

Likelihood based approaches to handling data below the quantification limit using NONMEM VI

(2008) Jae Eun Ahn et al.   JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS